back to homepage

Posts From admin

Bipolar Depression Market Poised for Robust Growth with Upcoming Novel Therapies and Improved Diagnostics

DelveInsight, a prominent market research company, has announced the publication of its latest report titled “Bipolar Depression Market Insights, Epidemiology, and Market Forecast 2036.” The Bipolar Depression report offers a

Read More

Inflammatory Bowel Disease Market to Undergo Major Transformation Through 2036 Fueled by Advanced Biologics, Precision Therapies, and Expanding Patient Population | DelveInsight

The BD market is witnessing remarkable growth driven by the increasing prevalence of Crohn’s disease and ulcerative colitis, rising adoption of advanced biologics and targeted therapies, growing awareness regarding early

Read More

Autosomal Dominant Polycystic Kidney Disease Market Set for Significant Expansion Through 2036 Driven by Rising Disease Burden and Emerging Disease-Modifying Therapies | DelveInsight

The ADPKD market is witnessing substantial growth driven by increasing diagnosed patient populations, advancements in genetic testing and diagnostic technologies, rising awareness regarding chronic kidney diseases, and growing adoption of

Read More

Osteoporosis Market to Witness Transformational Growth Through 2036 Driven by Rising Disease Burden and Emerging Bone-Building Therapies | DelveInsight

The Osteoporosis market is experiencing substantial growth driven by the increasing aging population, rising prevalence of fragility fractures, growing awareness regarding bone health, and expanding adoption of advanced anabolic and

Read More

Glioblastoma Multiforme Market to Witness Transformational Growth Opportunities by 2036 – DelveInsight | AstraZeneca, DNAtrix, Chimerix, Northwest Therapeutics, Bayer, Kazia Therapeutics, Aivita Bio

The Key Glioblastoma Multiforme Companies in the market include – Bayer, VBL Therapeutics, AstraZeneca, DNAtrix,Kintara Pharmaceuticals, Chimerix, KaryoPharma, VBI Vaccines, Kazia Therapeutics, AivitaBiomedical, Medicenna Therapeutics, Immunomic Therapeutics, Treovir, Istari Oncology,Inovio

Read More

Rett Syndrome Pipeline Gains Momentum as 20+ Leading Pharma Companies Advance Novel Therapies Through Expanding Clinical Trials | DelveInsight

DelveInsight’s, “Rett Syndrome Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Rett Syndrome pipeline landscape. It covers the Rett Syndrome pipeline drug profiles,

Read More

PD-1 and PD-L1 Inhibitors Competitive Landscape Witnesses Rapid Expansion as 180+ Biopharma Companies Advance Innovative Immuno-Oncology Therapies Toward Commercialization | DelveInsight

DelveInsight’s “PD-1 and PD-L1 Inhibitors Competitive landscape 2026” report provides comprehensive insights about 180+ companies and 200+ drugs in the PD-1 and PD-L1 Inhibitors Competitive landscape. It covers the therapeutics

Read More

$97.9 Million Q1 Revenue Delivering 69.9% Growth in Transformational Evolution of Company to a Powerful Global Digital Services Leader: IQSTEL, Inc. (Nasdaq: IQST)

$IQST On Track for $430 Million Revenue Target in Fiscal 2026 with Improved EBITDA via Operating Leverage, Disciplined Execution and Higher-Margin Digital Services   IQST Delivers Diversified Business with Divisions

Read More

Top 10 Brands of Cable Sleeve Manufacturer in China a 2026 Market Analysis

In 2026, global supply chain uncertainties are on the rise. Tariffs are changing, delivery times are fluctuating, compliance thresholds are increasing, and overseas buyers’ requirements for Chinese cable sleeve manufacturersare

Read More

GMAX Announces 2026 Online Dental Practice Conference Featuring Expert-Led Growth Training

GMAX Announces 2026 Online Dental Practice Conference Featuring Expert-Led Growth Training This Online Dental Conference Attendance is Limited to One Practice Per City. The GMAX 360 Dental Practice Success Conference

Read More